Answers are grounded in this paper and cite their sources.
Randomised study investigates guselkumab for remission in adults with giant cell arteritis, indicating limited effectiveness.
The study's primary endpoint (GC-free remission) was not met; results do not support the use of guselkumab in the treatment of GCA.
No takes yet. Share an insight, caveat, or question.
Makhzoum et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: